ExAblate 2100

DEVICE6 trials

Sponsors

InSightec, Stanford University

Conditions

BleedingBone CancerBone MetastasesLumbar Facet Joint PainPainPancreatic AdenocarcinomaPelvic PainUterine Fibroids

Phase 2

Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System

CompletedNCT01085565

InSightecBone Cancer, Bone Metastases, Pain

Start: 2010-03-31End: 2013-03-31Target: 50Updated: 2016-03-08

Unknown Phase

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

TerminatedNCT00981578

InSightecBone Metastases

Start: 2009-09-30End: 2016-11-14Updated: 2020-03-11

A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids

CompletedNCT01092988

InSightecBleeding, Pain, Uterine Fibroids

Start: 2010-03-31End: 2012-02-29Target: 40Updated: 2012-02-22

Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids

WithdrawnNCT01328067

InSightecBleeding, Pelvic Pain, Uterine Fibroids

Start: 2011-06-30End: 2017-06-30Updated: 2018-06-15

MR Guided High Intensity Focused Ultrasound for Lumbar Back Pain

WithdrawnNCT02291978

Stanford UniversityLumbar Facet Joint Pain

Start: 2014-10-31End: 2020-02-20Updated: 2020-02-24

Magnetic Resonance Guided High Intensity Focused Ultrasound in Advanced Pancreatic Adenocarcinoma Treatment

CompletedNCT04298242

Stanford UniversityPancreatic Adenocarcinoma

Start: 2020-11-22End: 2021-06-15Updated: 2023-11-22